These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24526736)

  • 41. Role of CD64, P53 and P21 proteins in the pathogenesis of the tubulo-interstitial syndrome in Masugi chronic nephritis.
    Rogovyi YE; Arkhipova LG; Dikal MV; Filipova LO; Mil' EN
    Bull Exp Biol Med; 2007 Oct; 144(4):511-4. PubMed ID: 18642700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation and characterization of DUSP11, a novel p53 target gene.
    Caprara G; Zamponi R; Melixetian M; Helin K
    J Cell Mol Med; 2009 Aug; 13(8B):2158-2170. PubMed ID: 19120688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100A14 interacts with S100A16 and regulates its expression in human cancer cells.
    Sapkota D; Costea DE; Ibrahim SO; Johannessen AC; Bruland O
    PLoS One; 2013; 8(9):e76058. PubMed ID: 24086685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21.
    Chen P; He Z; Wang J; Xu J; Jiang X; Chen Y; Liu X; Jiang J
    Front Cell Dev Biol; 2021; 9():682131. PubMed ID: 34900978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction: RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.
    Majumder M; House R; Palanisamy N; Qie S; Day TA; Neskey D; Diehl JA; Palanisamy V
    PLoS Genet; 2016 Oct; 12(10):e1006411. PubMed ID: 27783624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic property of cordycepin in cultivated Cordyceps militaris-mediated apoptosis in human leukemia cells.
    Chou SM; Lai WJ; Hong TW; Lai JY; Tsai SH; Chen YH; Yu SH; Kao CH; Chu R; Ding ST; Li TK; Shen TL
    Phytomedicine; 2014 Oct; 21(12):1516-24. PubMed ID: 25442260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.
    Hsieh MH; Tsai CH; Lin CC; Li TK; Hung TW; Chang LT; Hsin LW; Teng SC
    Cell Mol Life Sci; 2015 May; 72(9):1825-37. PubMed ID: 25430478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Regulatory Network and Role of the circRNA-miRNA-mRNA ceRNA Network in the Progression and the Immune Response of Wilms Tumor Based on RNA-Seq.
    Tian XM; Xiang B; Zhang ZX; Li YP; Shi QL; Li MJ; Li Q; Yu YH; Lu P; Liu F; Liu X; Lin T; He DW; Wei GH
    Front Genet; 2022; 13():849941. PubMed ID: 35559038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptome analysis reveals the encystment-related lncRNA expression profile and coexpressed mRNAs in Pseudourostyla cristata.
    Pan N; Bhatti MZ; Zhang W; Ni B; Fan X; Chen J
    Sci Rep; 2021 Apr; 11(1):8274. PubMed ID: 33859278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair.
    Blanchet A; Bourgmayer A; Kurtz JE; Mellitzer G; Gaiddon C
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis.
    McKie SJ; Neuman KC; Maxwell A
    Bioessays; 2021 Apr; 43(4):e2000286. PubMed ID: 33480441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
    Hou GX; Liu P; Yang J; Wen S
    PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.
    Bai Y; Li LD; Li J; Lu X
    J Ovarian Res; 2016 Jun; 9(1):35. PubMed ID: 27315793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. α-Catulin knockdown induces senescence in cancer cells.
    Fan LC; Chiang WF; Liang CH; Tsai YT; Wong TY; Chen KC; Hong TM; Chen YL
    Oncogene; 2011 Jun; 30(23):2610-21. PubMed ID: 21278790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
    Han J; Kim S; Yang JH; Nam SJ; Lee JE
    Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA topoisomerase III alpha regulates p53-mediated tumor suppression.
    Hsieh MY; Fan JR; Chang HW; Chen HC; Shen TL; Teng SC; Yeh YH; Li TK
    Clin Cancer Res; 2014 Mar; 20(6):1489-501. PubMed ID: 24526736
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.